Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments: second analysis of a randomised EORTC Melanoma Group trial comparing interferon-α2a (IFNα) and interleukin 2 (IL-2) with or without cisplatin - Keilholz, Ulrich; Schadendorf, Dirk (European journal of cancer, 2002)
Gesehen am 17.11.2020